GLASSIA Infusion Rate Study

Clinical trial NCT01651351 · COMPLETED

Trial details

NCT number: NCT01651351
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Alpha1-antitrypsin Deficiency Healthy Volunteers

Start date: 2012-07-31
Primary completion: 2013-01-16
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.